'Cures' Act in Congress Heavily Influenced by Lobb
Post# of 72440
Posted On: 11/29/2016 11:43:34 AM
'Cures' Act in Congress Heavily Influenced by Lobbyists
"AbbVie, the maker of Humira, a drug used to treat arthritis, ulcerative colitis and Crohn's disease, reported $7.7 million in lobbying expenditures in disclosures listing the bill as an issue. The company's total lobbying was $9.5 million this cycle."
Interesting...
http://www.nbcnews.com/health/health-news/cur...ts-n689531
"AbbVie, the maker of Humira, a drug used to treat arthritis, ulcerative colitis and Crohn's disease, reported $7.7 million in lobbying expenditures in disclosures listing the bill as an issue. The company's total lobbying was $9.5 million this cycle."
Interesting...
http://www.nbcnews.com/health/health-news/cur...ts-n689531
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼